Presentations

Q1 2024 Interim Report

Presentation –  08 May  2024

Virtual Meeting – 08 May 2024

 

Annual Report 2023

Presentation – 04 April  2024

Virtual Meeting – 04 April  2024

Investor Presentation

Presentation – 22 February 2024

Virtual Meeting – 22 February 2024

FDA Clearance Q&A

Presentation11 December 2023

Virtual Meeting11 December 2023

Interim Report Q3 2023

Presentation1 November 2023

Virtual Meeting1 November 2023

Interim Report Q2 2023

Presentation1 August 2023

Virtual Meeting1 August 2023

Rights Offering 2023

Presentation– 31 May 2023

Virtual Meeting– 31 May 2023

Virtual Meeting – 12 June 2023

Interim Report Q1 2023

Presentation10 May 2023

Virtual Meeting10 May 2023

Annual Report 2022

Presentation 30 March  2023

Virtual Meeting 30 March  2023

Interim Report Q3 2022

Presentation9 November 2022

Interim Report Q2 2022

HC Andersen Capital Presentation

Virtual Q&A29 June 2022

Interim Report Q1 2022

Annual Report 2021

Presentation06 April  2022

Virtual Meeting 06 April  2022

Interim Report Q3 2021

Investor Meeting Q3 2021 – 17 November 2021 – ENG

Investor Meeting Q3 2021 – 17 November 2021 – DK

Interim Report Q2 2021

Investor Meeting Q2 2021 – 18 August 2021 – ENG

Investor Meeting Q2 2021 – 18 August 2021 – DK

Interim Report Q1 2021

Investor Meeting Q1 2021 – 12 May 2021 – ENG

Investor Meeting Q1 2021 – 12 May 2021 – DK

Annual Report 2020

Presentation17 March 2021

Virtual Meeting17 March 2021

HC Andersen Capital Presentation

Presentation4 January 2021

Virtual Meeting4 January 2021

HC Andersen Capital/Nordea Small Cap Seminar

Presentation15 December 2020

Virtual Meeting15 December 2020

Interim Report Q3 2020

Investor Meeting Q3 2020 – 18 November 2020 – ENG

Investor Meeting Q3 2020 – 18 November 2020 – DK

HC Wainwright Conference

15 September 2020

Interim Report Q2 2020 

Investor Meeting Q2 2020 – 19 August 2020 – ENG

Investor Meeting Q2 2020 – 19 August 2020 – DK

Carlsquare Small & Mid-Cap Seminar 2020

26 June 2020

Interim Report Q1 2020 

Investor Meeting Q1 2020 – 7 May 2020 – ENG

Annual General Meeting 2020

14 April 2020

Pre-Emptive Rights Issue 2020

23 March 2020

Annual Report 2019

11 March 2020

Interim Report Q3 2019

Investor Meeting Q3 2019 – 16 December 2019

Interim Report Q2 2019

Investor Meeting Q2 2019 – 15 August 2019

Extraordinary General Meeting 2019

15 August 2019

Interim Report Q1 2019 

9 May 2019

Annual General Meeting 2019

18 March 2019

Annual Report 2018

22 February 2019

Biotech Showcase

8 January 2019